HEADER OXIDOREDUCTASE 30-JAN-08 2VN0
TITLE CYP2C8DH COMPLEXED WITH TROGLITAZONE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CYTOCHROME P450 2C8;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 28-490;
COMPND 5 SYNONYM: CYPIIC8, P450 FORM 1, P450 MP- 12/MP-20, P450 IIC2, S-
COMPND 6 MEPHENYTOIN 4-HYDROXYLASE;
COMPND 7 EC: 1.14.14.1;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI DH5[ALPHA];
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 668369;
SOURCE 7 EXPRESSION_SYSTEM_VECTOR: PCWORI
KEYWDS OXIDOREDUCTASE, ELECTRON TRANSPORT, ENDOPLASMIC RETICULUM, METAL-
KEYWDS 2 BINDING, PALMITIC ACID, HUMAN P450 2C8, TROGLITAZONE, POLYMORPHISM,
KEYWDS 3 MONOOXYGENASE, IRON, HEME, CYP2C8, MEMBRANE, MICROSOME,
KEYWDS 4 MONOOXYGENASES, INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR G.A.SCHOCH,J.K.YANO,S.SANSEN,C.D.STOUT,E.F.JOHNSON
REVDAT 7 13-DEC-23 2VN0 1 REMARK LINK
REVDAT 6 06-FEB-19 2VN0 1 REMARK
REVDAT 5 30-JAN-19 2VN0 1 REMARK
REVDAT 4 28-FEB-18 2VN0 1 SOURCE JRNL
REVDAT 3 24-FEB-09 2VN0 1 VERSN
REVDAT 2 01-JUL-08 2VN0 1 JRNL REMARK
REVDAT 1 29-APR-08 2VN0 0
JRNL AUTH G.A.SCHOCH,J.K.YANO,S.SANSEN,P.M.DANSETTE,C.D.STOUT,
JRNL AUTH 2 E.F.JOHNSON
JRNL TITL DETERMINANTS OF CYTOCHROME P450 2C8 SUBSTRATE BINDING:
JRNL TITL 2 STRUCTURES OF COMPLEXES WITH MONTELUKAST, TROGLITAZONE,
JRNL TITL 3 FELODIPINE, AND 9-CIS-RETINOIC ACID.
JRNL REF J. BIOL. CHEM. V. 283 17227 2008
JRNL REFN ISSN 0021-9258
JRNL PMID 18413310
JRNL DOI 10.1074/JBC.M802180200
REMARK 2
REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS 1.1
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : NULL
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.88
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1634289.670
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 23134
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.218
REMARK 3 FREE R VALUE : 0.254
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1167
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3609
REMARK 3 BIN R VALUE (WORKING SET) : 0.3160
REMARK 3 BIN FREE R VALUE : 0.3490
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 193
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3703
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 92
REMARK 3 SOLVENT ATOMS : 30
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 48.50
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.90
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -5.88000
REMARK 3 B22 (A**2) : 12.90000
REMARK 3 B33 (A**2) : -7.02000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35
REMARK 3 ESD FROM SIGMAA (A) : 0.39
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 1.400
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.870
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.34
REMARK 3 BSOL : 32.84
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : NULL
REMARK 3 TOPOLOGY FILE 1 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 2VN0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-JAN-08.
REMARK 100 THE DEPOSITION ID IS D_1290035147.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 12-MAY-06
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 7.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : SSRL
REMARK 200 BEAMLINE : BL9-1
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946
REMARK 200 MONOCHROMATOR : SIDE-SCATTERING CUBEROOT I- BEAM
REMARK 200 BENT SINGLE CRYSTAL ASYMETRIC
REMARK 200 CUT 12.2 DEGS.
REMARK 200 OPTICS : VERTICAL FOCUSING MIRROR SINGLE
REMARK 200 CRYSTAL SI(311) BENT
REMARK 200 MONOCHROMATOR (HORIZONTAL
REMARK 200 FOCUSING)
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC CCD
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200 DATA SCALING SOFTWARE : SCALA
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23135
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700
REMARK 200 RESOLUTION RANGE LOW (A) : 47.900
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 7.900
REMARK 200 R MERGE (I) : 0.06000
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.77
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 8.00
REMARK 200 R MERGE FOR SHELL (I) : 0.52000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: PDB ENTRY 1PQ2
REMARK 200
REMARK 200 REMARK: NONE
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 67.80
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.82
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, HEPES, LISO4, MEOH, PH 7.5,
REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z
REMARK 290 3555 -X,Y,-Z
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z+1/2
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.10000
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 68.04500
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 81.62000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.10000
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 68.04500
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 81.62000
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.10000
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 68.04500
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 81.62000
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.10000
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 68.04500
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 81.62000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PQS
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 19
REMARK 465 ALA A 20
REMARK 465 LYS A 21
REMARK 465 LYS A 22
REMARK 465 THR A 23
REMARK 465 SER A 24
REMARK 465 SER A 25
REMARK 465 LYS A 26
REMARK 465 GLY A 27
REMARK 465 HIS A 492
REMARK 465 HIS A 493
REMARK 465 HIS A 494
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 O ILE A 355 OG SER A 359 2.17
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO A 37 C - N - CA ANGL. DEV. = 10.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 31 -176.11 -53.18
REMARK 500 PRO A 37 -36.36 -15.65
REMARK 500 ASP A 49 53.22 -161.06
REMARK 500 ILE A 88 -66.31 -97.38
REMARK 500 MET A 136 57.99 -148.40
REMARK 500 THR A 159 4.99 -69.67
REMARK 500 ALA A 161 5.23 57.72
REMARK 500 THR A 167 -70.90 -33.53
REMARK 500 GLN A 184 -91.14 119.10
REMARK 500 SER A 280 129.02 -34.97
REMARK 500 THR A 299 -76.17 -85.10
REMARK 500 ARG A 377 -127.73 56.62
REMARK 500 ASN A 378 30.95 -96.96
REMARK 500 LEU A 390 83.93 -65.91
REMARK 500 LYS A 415 -38.98 -39.87
REMARK 500 SER A 429 -153.51 76.90
REMARK 500 CYS A 435 125.12 -32.33
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 HEM A 500 FE
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 CYS A 435 SG
REMARK 620 2 HEM A 500 NA 91.6
REMARK 620 3 HEM A 500 NB 92.4 89.1
REMARK 620 4 HEM A 500 NC 83.3 174.8 91.8
REMARK 620 5 HEM A 500 ND 88.0 89.8 178.8 89.3
REMARK 620 N 1 2 3 4
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TDZ A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PLM A 502
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1PQ2 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROMEP450 2C8
REMARK 900 RELATED ID: 2NNJ RELATED DB: PDB
REMARK 900 CYP2C8DH COMPLEXED WITH FELODIPINE
REMARK 900 RELATED ID: 2NNH RELATED DB: PDB
REMARK 900 CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
REMARK 900 RELATED ID: 2NNI RELATED DB: PDB
REMARK 900 CYP2C8DH COMPLEXED WITH MONTELUKAST
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 REPLACEMENT OF RESIDUES 1-27 WITH THE SEQUENCE MAKKTSSKG,
REMARK 999 ADDITION OF A C-TERMINAL 4 RESIDUE HISTIDINE TAG (RESIDUES
REMARK 999 491-494)
DBREF 2VN0 A 19 27 PDB 2VN0 2VN0 19 27
DBREF 2VN0 A 28 490 UNP P10632 CP2C8_HUMAN 28 490
DBREF 2VN0 A 491 494 PDB 2VN0 2VN0 491 494
SEQRES 1 A 476 MET ALA LYS LYS THR SER SER LYS GLY LYS LEU PRO PRO
SEQRES 2 A 476 GLY PRO THR PRO LEU PRO ILE ILE GLY ASN MET LEU GLN
SEQRES 3 A 476 ILE ASP VAL LYS ASP ILE CYS LYS SER PHE THR ASN PHE
SEQRES 4 A 476 SER LYS VAL TYR GLY PRO VAL PHE THR VAL TYR PHE GLY
SEQRES 5 A 476 MET ASN PRO ILE VAL VAL PHE HIS GLY TYR GLU ALA VAL
SEQRES 6 A 476 LYS GLU ALA LEU ILE ASP ASN GLY GLU GLU PHE SER GLY
SEQRES 7 A 476 ARG GLY ASN SER PRO ILE SER GLN ARG ILE THR LYS GLY
SEQRES 8 A 476 LEU GLY ILE ILE SER SER ASN GLY LYS ARG TRP LYS GLU
SEQRES 9 A 476 ILE ARG ARG PHE SER LEU THR THR LEU ARG ASN PHE GLY
SEQRES 10 A 476 MET GLY LYS ARG SER ILE GLU ASP ARG VAL GLN GLU GLU
SEQRES 11 A 476 ALA HIS CYS LEU VAL GLU GLU LEU ARG LYS THR LYS ALA
SEQRES 12 A 476 SER PRO CYS ASP PRO THR PHE ILE LEU GLY CYS ALA PRO
SEQRES 13 A 476 CYS ASN VAL ILE CYS SER VAL VAL PHE GLN LYS ARG PHE
SEQRES 14 A 476 ASP TYR LYS ASP GLN ASN PHE LEU THR LEU MET LYS ARG
SEQRES 15 A 476 PHE ASN GLU ASN PHE ARG ILE LEU ASN SER PRO TRP ILE
SEQRES 16 A 476 GLN VAL CYS ASN ASN PHE PRO LEU LEU ILE ASP CYS PHE
SEQRES 17 A 476 PRO GLY THR HIS ASN LYS VAL LEU LYS ASN VAL ALA LEU
SEQRES 18 A 476 THR ARG SER TYR ILE ARG GLU LYS VAL LYS GLU HIS GLN
SEQRES 19 A 476 ALA SER LEU ASP VAL ASN ASN PRO ARG ASP PHE ILE ASP
SEQRES 20 A 476 CYS PHE LEU ILE LYS MET GLU GLN GLU LYS ASP ASN GLN
SEQRES 21 A 476 LYS SER GLU PHE ASN ILE GLU ASN LEU VAL GLY THR VAL
SEQRES 22 A 476 ALA ASP LEU PHE VAL ALA GLY THR GLU THR THR SER THR
SEQRES 23 A 476 THR LEU ARG TYR GLY LEU LEU LEU LEU LEU LYS HIS PRO
SEQRES 24 A 476 GLU VAL THR ALA LYS VAL GLN GLU GLU ILE ASP HIS VAL
SEQRES 25 A 476 ILE GLY ARG HIS ARG SER PRO CYS MET GLN ASP ARG SER
SEQRES 26 A 476 HIS MET PRO TYR THR ASP ALA VAL VAL HIS GLU ILE GLN
SEQRES 27 A 476 ARG TYR SER ASP LEU VAL PRO THR GLY VAL PRO HIS ALA
SEQRES 28 A 476 VAL THR THR ASP THR LYS PHE ARG ASN TYR LEU ILE PRO
SEQRES 29 A 476 LYS GLY THR THR ILE MET ALA LEU LEU THR SER VAL LEU
SEQRES 30 A 476 HIS ASP ASP LYS GLU PHE PRO ASN PRO ASN ILE PHE ASP
SEQRES 31 A 476 PRO GLY HIS PHE LEU ASP LYS ASN GLY ASN PHE LYS LYS
SEQRES 32 A 476 SER ASP TYR PHE MET PRO PHE SER ALA GLY LYS ARG ILE
SEQRES 33 A 476 CYS ALA GLY GLU GLY LEU ALA ARG MET GLU LEU PHE LEU
SEQRES 34 A 476 PHE LEU THR THR ILE LEU GLN ASN PHE ASN LEU LYS SER
SEQRES 35 A 476 VAL ASP ASP LEU LYS ASN LEU ASN THR THR ALA VAL THR
SEQRES 36 A 476 LYS GLY ILE VAL SER LEU PRO PRO SER TYR GLN ILE CYS
SEQRES 37 A 476 PHE ILE PRO VAL HIS HIS HIS HIS
HET HEM A 500 43
HET TDZ A 501 31
HET PLM A 502 18
HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE
HETNAM TDZ (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-
HETNAM 2 TDZ DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-
HETNAM 3 TDZ THIAZOLIDINE-2,4-DIONE
HETNAM PLM PALMITIC ACID
HETSYN HEM HEME
HETSYN TDZ TROGLITAZONE
FORMUL 2 HEM C34 H32 FE N4 O4
FORMUL 3 TDZ C24 H27 N O5 S
FORMUL 4 PLM C16 H32 O2
FORMUL 5 HOH *30(H2 O)
HELIX 1 1 ASN A 41 ILE A 45 5 5
HELIX 2 2 ASP A 49 GLY A 62 1 14
HELIX 3 3 GLY A 79 ILE A 88 1 10
HELIX 4 4 SER A 100 LYS A 108 1 9
HELIX 5 5 ASN A 116 LEU A 131 1 16
HELIX 6 6 SER A 140 THR A 159 1 20
HELIX 7 7 PRO A 166 PHE A 183 1 18
HELIX 8 8 ASP A 191 ASN A 209 1 19
HELIX 9 9 SER A 210 PHE A 219 1 10
HELIX 10 10 PRO A 220 CYS A 225 5 6
HELIX 11 11 PHE A 226 SER A 254 1 29
HELIX 12 12 ASP A 262 LYS A 275 1 14
HELIX 13 13 ASN A 283 THR A 299 1 17
HELIX 14 14 THR A 299 HIS A 316 1 18
HELIX 15 15 HIS A 316 ILE A 331 1 16
HELIX 16 16 CYS A 338 HIS A 344 5 7
HELIX 17 17 MET A 345 ASP A 360 1 16
HELIX 18 18 LEU A 390 HIS A 396 1 7
HELIX 19 19 ASP A 408 PHE A 412 5 5
HELIX 20 20 ALA A 430 ILE A 434 5 5
HELIX 21 21 GLY A 437 GLN A 454 1 18
HELIX 22 22 ASP A 463 LEU A 467 5 5
SHEET 1 AA 5 VAL A 64 PHE A 69 0
SHEET 2 AA 5 ASN A 72 PHE A 77 -1 O ASN A 72 N PHE A 69
SHEET 3 AA 5 THR A 386 ALA A 389 1 O THR A 386 N VAL A 75
SHEET 4 AA 5 HIS A 368 ALA A 369 -1 O HIS A 368 N ILE A 387
SHEET 5 AA 5 GLY A 96 ARG A 97 -1 O GLY A 96 N ALA A 369
SHEET 1 AB 3 PRO A 163 CYS A 164 0
SHEET 2 AB 3 ILE A 485 PRO A 489 -1 O ILE A 485 N CYS A 164
SHEET 3 AB 3 PHE A 456 SER A 460 -1 O ASN A 457 N ILE A 488
SHEET 1 AC 2 THR A 374 PHE A 376 0
SHEET 2 AC 2 TYR A 379 ILE A 381 -1 O TYR A 379 N PHE A 376
LINK SG CYS A 435 FE HEM A 500 1555 1555 2.27
SITE 1 AC1 19 ARG A 97 ILE A 112 TRP A 120 ARG A 124
SITE 2 AC1 19 ALA A 297 GLY A 298 THR A 301 THR A 302
SITE 3 AC1 19 THR A 305 LEU A 361 VAL A 366 HIS A 368
SITE 4 AC1 19 PRO A 427 PHE A 428 SER A 429 ARG A 433
SITE 5 AC1 19 CYS A 435 ALA A 436 GLU A 444
SITE 1 AC2 8 ILE A 106 PHE A 201 ASN A 204 PHE A 205
SITE 2 AC2 8 LEU A 208 ARG A 241 VAL A 296 GLU A 300
SITE 1 AC3 7 ARG A 105 ILE A 106 PHE A 226 PRO A 227
SITE 2 AC3 7 GLY A 228 THR A 229 LEU A 234
CRYST1 74.200 136.090 163.240 90.00 90.00 90.00 I 2 2 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013477 0.000000 0.000000 0.00000
SCALE2 0.000000 0.007348 0.000000 0.00000
SCALE3 0.000000 0.000000 0.006126 0.00000